Nifty

:

22055.20

Sensex

:

72664.47

97.70 (0.44%)
260.30 (0.36%)

Login

Nifty
Sensex

:
:

22055.20
72664.47

97.70 (0.44%)
260.30 (0.36%)

Biofil Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

49/99

BSE: 524396 | NSE: BIOFILCHEM

Watchlist

NSE BSE

67.95

10-May-2024

Open
High
Low
Previous Close

66.10
68.80
66.10
66.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

27181
18.39
79.00
41.30

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

110.69
165.46
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

111.20
N/A
6.23

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.40
5.37
-5.64

EBITDA CAGR (%)

10 Years
5 Years
3 Years

2.00
2.78
-6.07

PAT CAGR (%)

10 Years
5 Years
3 Years

0.74
3.13
-23.28

P:E (Median)

8 Years
5 Years
3 Years

40.59
117.32
136.83

P:BV (Average)

8 Years
5 Years
3 Years

5.99
5.99
5.49

EV:EBITDA (Average)

8 Years
5 Years
3 Years

36.47
50.42
60.21

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 5.03 1.49 237.58% 17.37 2.62 562.98% 2.43 12.31 -80.26% 13.62 1.65 725.45%
Expenses 4.84 1.27 281.10% 17.13 2.46 596.34% 2.01 11.93 -83.15% 13.21 1.50 780.67%
EBITDA 0.19 0.23 -17.39% 0.24 0.16 50.00% 0.42 0.38 10.53% 0.41 0.14 192.86%
EBIDTM 3.82% 15.19% 1.37% 5.88% 17.17% 3.06% 2.99% 8.63%
Other Income 0.03 0.02 50.00% 0.03 0.02 50.00% 0.03 0.02 50.00% 0.03 0.03 0.00%
Interest 0.00 0.01 -100.00% 0.01 0.01 0.00% 0.01 0.01 0.00% 0.01 0.01 0.00%
Depreciation 0.11 0.11 0.00% 0.11 0.11 0.00% 0.11 0.11 0.00% 0.11 0.12 -8.33%
PBT 0.11 0.13 -15.38% 0.15 0.06 150.00% 0.33 0.28 17.86% 0.32 0.04 700.00%
Tax 0.02 0.03 -33.33% 0.03 0.02 50.00% 0.08 0.07 14.29% 0.11 0.07 57.14%
PAT 0.09 0.10 -10.00% 0.12 0.05 140.00% 0.25 0.21 19.05% 0.21 -0.03 -
PATM 1.85% 6.63% 0.71% 1.72% 10.07% 1.68% 1.53% -1.76%
EPS 0.06 0.06 0.00% 0.08 0.03 166.67% 0.15 0.13 15.38% 0.13 -0.02 -

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 38.45 30.04 22.38 35.75 29.69 23.13 12.36 13.45 13.17 5.86 7.17 Net Sales Growth 112.78% 34.23% -37.40% 20.41% 28.36% 87.14% -8.10% 2.13% 124.74% -18.27% Cost Of Goods Sold 35.55 27.42 19.46 32.43 25.31 19.99 9.77 8.51 10.53 3.85 4.73 Gross Profit 2.90 2.61 2.92 3.32 4.38 3.14 2.59 4.94 2.65 2.01 2.44 GP Margin 7.55% 8.69% 13.05% 9.29% 14.75% 13.58% 20.95% 36.73% 20.12% 34.30% 34.03% Total Expenditure 37.19 28.87 21.05 34.15 27.87 22.11 11.42 10.83 12.30 5.13 6.21 Power & Fuel Cost - 0.33 0.30 0.29 0.49 0.37 0.33 0.44 0.37 0.35 0.28 % Of Sales - 1.10% 1.34% 0.81% 1.65% 1.60% 2.67% 3.27% 2.81% 5.97% 3.91% Employee Cost - 0.62 0.79 0.75 0.86 0.89 0.73 0.53 0.48 0.50 0.41 % Of Sales - 2.06% 3.53% 2.10% 2.90% 3.85% 5.91% 3.94% 3.64% 8.53% 5.72% Manufacturing Exp. - 0.16 0.15 0.30 0.55 0.20 0.14 0.47 0.49 0.19 0.27 % Of Sales - 0.53% 0.67% 0.84% 1.85% 0.86% 1.13% 3.49% 3.72% 3.24% 3.77% General & Admin Exp. - 0.24 0.30 0.29 0.24 0.24 0.39 0.48 0.32 0.16 0.15 % Of Sales - 0.80% 1.34% 0.81% 0.81% 1.04% 3.16% 3.57% 2.43% 2.73% 2.09% Selling & Distn. Exp. - 0.02 0.01 0.01 0.38 0.39 0.04 0.31 0.06 0.00 0.29 % Of Sales - 0.07% 0.04% 0.03% 1.28% 1.69% 0.32% 2.30% 0.46% 0% 4.04% Miscellaneous Exp. - 0.08 0.05 0.08 0.03 0.02 0.02 0.09 0.05 0.08 0.29 % Of Sales - 0.27% 0.22% 0.22% 0.10% 0.09% 0.16% 0.67% 0.38% 1.37% 0.98% EBITDA 1.26 1.17 1.33 1.60 1.82 1.02 0.94 2.62 0.87 0.73 0.96 EBITDA Margin 3.28% 3.89% 5.94% 4.48% 6.13% 4.41% 7.61% 19.48% 6.61% 12.46% 13.39% Other Income 0.12 0.10 0.15 0.80 0.17 0.10 0.10 0.14 0.53 0.46 0.06 Interest 0.03 0.04 0.04 0.07 0.12 0.16 0.15 0.16 0.15 0.21 0.15 Depreciation 0.44 0.43 0.43 0.41 0.41 0.37 0.30 0.28 0.26 0.25 0.22 PBT 0.91 0.79 1.01 1.92 1.46 0.60 0.59 2.31 0.98 0.74 0.65 Tax 0.24 0.23 0.32 0.68 0.26 0.12 0.12 0.52 0.20 0.15 0.13 Tax Rate 26.37% 29.11% 31.68% 35.42% 17.81% 20.00% 20.34% 22.51% 20.41% 20.27% 20.00% PAT 0.67 0.56 0.70 1.24 1.21 0.48 0.47 1.79 0.78 0.59 0.52 PAT before Minority Interest 0.67 0.56 0.70 1.24 1.21 0.48 0.47 1.79 0.78 0.59 0.52 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.74% 1.86% 3.13% 3.47% 4.08% 2.08% 3.80% 13.31% 5.92% 10.07% 7.25% PAT Growth 103.03% -20.00% -43.55% 2.48% 152.08% 2.13% -73.74% 129.49% 32.20% 13.46% EPS 0.41 0.34 0.43 0.76 0.74 0.29 0.29 1.10 0.48 0.36 0.32

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 17.30 16.84 16.13 14.88 13.65 13.17 12.70 10.91 8.41 7.86 Share Capital 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 Total Reserves 1.03 0.56 -0.14 -1.39 -2.62 -3.11 -3.58 -5.37 -7.86 -8.41 Non-Current Liabilities 0.38 0.40 0.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 13.73 1.49 16.75 27.48 10.56 10.99 9.14 13.23 5.34 6.74 Trade Payables 12.65 0.60 15.85 25.92 8.58 9.14 7.10 11.59 2.11 3.64 Other Current Liabilities 0.32 0.16 0.14 0.12 0.23 0.17 0.12 0.00 0.00 0.00 Short Term Borrowings 0.52 0.46 0.43 1.19 1.64 1.56 1.43 1.37 2.98 2.87 Short Term Provisions 0.23 0.27 0.33 0.25 0.12 0.11 0.50 0.26 0.25 0.23 Total Liabilities 31.41 18.73 33.24 42.36 24.21 24.16 21.84 24.14 13.75 14.60 Net Block 9.00 9.42 9.78 10.09 10.29 9.25 9.16 8.98 9.06 9.17 Gross Block 11.63 11.62 11.55 11.45 11.24 9.83 9.45 11.04 10.85 10.68 Accumulated Depreciation 2.63 2.20 1.77 1.36 0.95 0.58 0.29 2.06 1.79 1.51 Non Current Assets 9.00 9.42 9.78 10.09 10.29 9.25 9.16 8.98 9.06 9.17 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 22.41 9.31 23.46 32.27 13.92 14.91 12.68 15.16 4.70 5.43 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 1.21 1.29 4.34 1.69 1.19 1.02 0.17 0.10 0.17 0.27 Sundry Debtors 20.50 7.17 17.22 29.71 12.03 12.98 11.46 13.98 3.65 4.10 Cash & Bank 0.04 0.14 0.44 0.26 0.14 0.37 0.31 0.18 0.13 0.18 Other Current Assets 0.65 0.50 1.41 0.19 0.57 0.53 0.74 0.89 0.75 0.87 Short Term Loans & Adv. 0.27 0.21 0.05 0.43 0.44 0.43 0.59 0.89 0.75 0.87 Net Current Assets 8.68 7.82 6.71 4.79 3.36 3.92 3.53 1.93 -0.64 -1.31 Total Assets 31.41 18.73 33.24 42.36 24.21 24.16 21.84 24.14 13.76 14.60

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -0.11 -0.22 1.11 0.89 1.26 0.46 0.71 0.14 0.01 0.21 PBT 0.79 1.01 1.92 1.46 0.60 0.59 2.31 0.98 0.74 0.65 Adjustment 0.38 0.48 0.48 0.56 0.53 0.45 0.45 0.42 0.46 0.37 Changes in Working Capital -1.05 -1.40 -0.62 -0.87 0.25 -0.07 -1.84 -0.96 -0.84 -0.52 Cash after chg. in Working capital 0.12 0.10 1.79 1.15 1.37 0.97 0.91 0.44 0.35 0.50 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.15 -0.21 -0.15 Tax Paid -0.23 -0.32 -0.68 -0.25 -0.11 -0.50 -0.20 -0.15 -0.13 -0.14 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.01 -0.07 -0.10 -0.21 -1.41 -0.38 -0.48 -0.19 -0.17 -0.24 Net Fixed Assets -0.01 -0.07 -0.10 -0.21 -1.41 -0.38 1.59 -0.19 -0.17 -0.24 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.00 0.00 0.00 0.00 0.00 0.00 -2.07 0.00 0.00 0.00 Cash from Financing Activity 0.02 -0.01 -0.83 -0.57 -0.08 -0.02 -0.11 0.10 0.11 0.08 Net Cash Inflow / Outflow -0.11 -0.30 0.18 0.12 -0.24 0.06 0.13 0.05 -0.05 0.05 Opening Cash & Equivalents 0.14 0.44 0.26 0.14 0.37 0.31 0.18 0.13 0.18 0.13 Closing Cash & Equivalent 0.04 0.14 0.44 0.26 0.14 0.37 0.31 0.18 0.13 0.18

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 10.63 10.35 9.91 9.15 8.39 8.09 7.80 4.39 2.85 2.51 ROA 2.24% 2.69% 3.28% 3.63% 1.99% 2.05% 7.81% 4.13% 4.14% 3.68% ROE 3.28% 4.24% 8.01% 8.46% 3.60% 3.64% 18.09% 13.28% 13.47% 13.53% ROCE 4.76% 6.23% 12.18% 10.12% 5.06% 5.13% 21.86% 14.04% 12.97% 12.09% Fixed Asset Turnover 2.58 1.93 3.11 2.62 2.19 1.28 1.31 1.20 0.54 0.68 Receivable days 168.17 198.88 239.55 256.53 197.31 360.94 345.20 244.36 241.46 189.36 Inventory Days 15.23 45.97 30.82 17.72 17.48 17.59 3.56 3.64 13.70 15.17 Payable days 88.15 154.25 235.08 223.27 146.68 239.24 317.92 205.27 204.15 204.37 Cash Conversion Cycle 95.25 90.60 35.29 50.98 68.12 139.29 30.84 42.72 51.02 0.15 Total Debt/Equity 0.03 0.03 0.03 0.08 0.12 0.12 0.11 0.19 0.64 0.70 Interest Cover 19.66 26.00 29.18 12.96 4.70 4.86 15.12 7.46 4.51 5.24

Top Investors:

starline equifin private limited

ksl and industries limited

kishor himmatsinh jhala

gom industries ltd

Annual Reports:

News Update:

Biofil Chem & Pharma - Quarterly Results
6th Feb 2024, 20:47 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback